Literature DB >> 33562585

Development and Validation of an Automated Zone Fluidics-Based Sensor for In Vitro Dissolution Studies of Captopril Using Total Error Concept.

Theano D Karakosta1, Paraskevas D Tzanavaras2, Constantinos K Zacharis3.   

Abstract

In the present research, a zone fluidics-based automated sensor for the analysis of captopril in in vitro dissolution samples is reported. Captopril is reacted under flow conditions with Ni(II) (10 mmol L-1) in alkaline medium (0.15% v/v NH3) to form a stable derivate, which is monitored spectrophotometrically at 340 nm. The chemical and instrumental parameters were carefully investigated and optimized. The validation of the developed method was performed in the range of 5 to 120% of the expected maximum concentration using the accuracy profiles as a graphical decision-making tool. The β-expectation tolerance intervals did not exceed the acceptance criteria of ±10%, which means that 95% of future results will be encompassed in the defined bias limits. The variation of the relative bias ranged between -2.3% and 3.5% and the RSD values for repeatability and intermediate precision were lower than 2.3% in all cases. The limit of detection (LOD), and the lower and the upper limit of quantification (LLOQ, ULOQ) were satisfactory and found to be 1%, 5% and 120% (corresponding to 0.6, 2.78 and 66.67 μg mL-1 in dissolution medium). The developed method was successfully applied for the analysis of captopril in dissolution tests of two commercially available batches.

Entities:  

Keywords:  accuracy profiles; captopril; dissolution; validation; zone fluidics

Mesh:

Substances:

Year:  2021        PMID: 33562585      PMCID: PMC7914990          DOI: 10.3390/molecules26040824

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  16 in total

1.  Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--Part I.

Authors:  Ph Hubert; J-J Nguyen-Huu; B Boulanger; E Chapuzet; P Chiap; N Cohen; P-A Compagnon; W Dewé; M Feinberg; M Lallier; M Laurentie; N Mercier; G Muzard; C Nivet; L Valat
Journal:  J Pharm Biomed Anal       Date:  2004-11-15       Impact factor: 3.935

2.  Automated measurement of permeation and dissolution of propranolol HCl tablets using sequential injection analysis.

Authors:  Stephan A Motz; Jana Klimundová; Ulrich F Schaefer; Stefan Balbach; Thomas Eichinger; Petr Solich; Claus-Michael Lehr
Journal:  Anal Chim Acta       Date:  2006-08-05       Impact factor: 6.558

Review 3.  Validation of analytical methods based on accuracy profiles.

Authors:  Max Feinberg
Journal:  J Chromatogr A       Date:  2007-02-11       Impact factor: 4.759

4.  Chemiluminometric determination of captopril in a multi-pumping flow system.

Authors:  S Sofia M Rodrigues; João L M Santos
Journal:  Talanta       Date:  2012-02-25       Impact factor: 6.057

5.  Automated determination of total captopril in urine by liquid chromatography with post-column derivatization coupled to on-line solid phase extraction in a sequential injection manifold.

Authors:  Theano D Karakosta; Paraskevas D Tzanavaras; Demetrius G Themelis
Journal:  Talanta       Date:  2011-11-18       Impact factor: 6.057

Review 6.  Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies.

Authors:  Elise Grignard; Robert Taylor; Mark McAllister; Karl Box; Nikoletta Fotaki
Journal:  Eur J Pharm Sci       Date:  2016-12-07       Impact factor: 4.384

7.  Determination of Albumin, Glucose, and Creatinine Employing a Single Sequential Injection Lab-at-Valve with Mono-Segmented Flow System Enabling In-Line Dilution, In-Line Single-Standard Calibration, and In-Line Standard Addition.

Authors:  Kanokwan Kiwfo; Wasin Wongwilai; Tadao Sakai; Norio Teshima; Kate Grudpan
Journal:  Molecules       Date:  2020-04-04       Impact factor: 4.411

8.  Oral Treatment of Spontaneously Hypertensive Rats with Captopril-Surface Functionalized Furosemide-Loaded Multi-Wall Lipid-Core Nanocapsules.

Authors:  Cecilia B Michalowski; Marcelo D Arbo; Louise Altknecht; Andréia N Anciuti; Angélica S G Abreu; Luciana M R Alencar; Adriana R Pohlmann; Solange C Garcia; Sílvia S Guterres
Journal:  Pharmaceutics       Date:  2020-01-18       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.